Tenon Medical, Inc. (TNON)
| Market Cap | 8.60M |
| Revenue (ttm) | 3.94M |
| Net Income (ttm) | -12.56M |
| Shares Out | 11.30M |
| EPS (ttm) | -1.70 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,904 |
| Open | 0.762 |
| Previous Close | 0.787 |
| Day's Range | 0.761 - 0.800 |
| 52-Week Range | 0.641 - 2.480 |
| Beta | 1.25 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 5, 2026 |
About TNON
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along it... [Read more]
Financial Performance
In 2025, Tenon Medical's revenue was $3.94 million, an increase of 20.35% compared to the previous year's $3.28 million. Losses were -$12.56 million, -8.17% less than in 2024.
Financial StatementsNews
Tenon Medical Earnings Call Transcript: Q4 2025
Record 2025 revenue rose 20% year-over-year, with Q4 up 92% on strong adoption of Catamaran and SImmetry+. Gross margin improved to 69% in Q4, and new FDA clearance plus $7.15M in financing support growth plans for 2026.
Tenon(R) Medical Reports Fourth Quarter and Full Year 2025 Financial Results
~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~ ~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second H...
WallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 Million
JERSEY CITY, N.J., March 12, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announces the closing of Tenon Medical, Inc. (NAS...
Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million
LOS GATOS, CA / ACCESS Newswire / March 12, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders,...
Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion
Expanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth Strategy LOS GATOS, CA / ACCESS Newswire / February 18, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "...
Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues
Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year LOS GATOS...
Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry(R)+ SI Joint Fusion System
~ Procedures Completed in Various Spine Centers of Excellence Throughout the Country Including Florida, Arizona, Ohio, and Texas ~ ~ SImmetry+ combines 3D-printed titanium implants, a robust joint dec...
Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing
LOS GATOS, CA / ACCESS Newswire / November 14, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorde...
Tenon Medical Earnings Call Transcript: Q3 2025
Q3 2025 revenue grew 32% year-over-year to $1.2 million, driven by record Catamaran procedures and initial SiVantage contributions. Gross margin improved to 66%, and the company ended the quarter with $3.4 million in cash, later raising $2.85 million more.
Tenon(R) Medical Reports Third Quarter 2025 Financial Results
~ Record revenue of $1.2 million, a 32% year-over-year increase, reflecting record volume in Catamaran® SI Joint Fusion System procedures and the addition of SImmetry® SI Joint Fusion Product Sales ~ ...
Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing
~ Strategically Placed PIPE With Industry Supportive Investor Cohort ~ LOS GATOS, CA / ACCESS Newswire / November 11, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company tra...
Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results
LOS GATOS, CA / ACCESS Newswire / November 3, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorder...
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
~Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical approaches~ ~SImmetry+'s New 3...
Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months
~ Clinically Significant Patient Outcomes Demonstrate Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at 12-Month Analysis ~ ~ 83% of Patients ...
Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System
~Full Commercial Launch with Expanded Number of Instrument Sets and Field Support to Meet Growing Market Demand ~ ~ New SI Joint Fixation Device Offers a Reduced Profile in Implant Size Providing Phys...
Tenon Medical Earnings Call Transcript: Q2 2025
Q2 2025 saw a strategic acquisition, expanded product offerings, and disciplined cost reductions. Revenue and gross margin declined year-over-year, but integration of CyVantage and new product launches are expected to drive a rapid rebound in growth.
Tenon Medical Reports Second Quarter 2025 Financial Results
~ Recently Announced Strategic Acquisition of SiVantage Portfolio Energizes Tenon's Commercial Organization and Accelerates Topline Growth ~ ~ FDA Clearance Unlocks New Sacro-Pelvic Market Opportunity...
Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
LOS GATOS, CA / ACCESS Newswire / August 5, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...
Tenon Medical(R) Expands Sacro-Pelvic Fusion Portfolio with Strategic Asset Acquisition
~ SiVantage Portfolio Acquisition Enhances Tenon's Sacroiliac Joint Fusion Capabilities with a Unique Multi-Product, Multi-Approach Solution ~ ~ Significant Enhancement of Tenon Medical's Commercial L...
Tenon Medical Announces Initial Case Series Utilizing Catamaran(R) SI Joint Fusion System to Enhance Stabilization of the SI Joint for Patients Undergoing Lumbar Fusion
~ Andrew J. Trontis, MD from Progressive Spine and Orthopaedics, (Englewood, NJ) Completes Initial Case Series ~ LOS GATOS, CA / ACCESS Newswire / June 12, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("T...
Tenon Medical Earnings Call Transcript: Q1 2025
Revenue grew 1% year-over-year in Q1 2025, with gross margin declining to 44% amid stable operating expenses. FDA clearance for spinal fusion augmentation and the upcoming Catamaran SE launch are expected to drive future growth, supported by a strengthened cash position.
Tenon Medical Reports First Quarter 2025 Financial Results
~ FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~ ~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and Int...
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
LOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...
Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Jo...
Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Jo...